StoryPitch™ Ready

Stand out from the crowd

Our program for founders and CEOs of pre-seed to series A startups

Today, the life sciences and biotech sectors are awash with cash. Getting in front of investors has become much easier with many encounters and first-time meetings taking place virtually. But while there is more money to fight over, competition is fierce.

StoryPitch™ Ready is our trusted service to make sure you can convey to investors the full value of your innovation.

We start by analyzing your existing material to spot where we can strengthen your fundraising pitch.

Then we work closely with you to clarify the structure and messaging of your existing narrative.

Everything we do is based on our unique StoryPitch™ methodology. A well-tested system built around five key principles to pitch a winning story.

Our team of expert designers and content strategists then produce a professional pitch deck. One that shows investors what makes your science special ­– and why you’re the team they should invest in.

We have worked with over a hundred startups just like yours, who went on to win pitch competitions, get funded, and take their organization to the next level.

Ready to Stand out from the crowd? Let’s talk!


Is StoryPitch™ Ready right for you?

  • You are preparing for pre-seed to series A fundraising
  • You need to differentiate yourself from the competition
  • You feel your current deck lacks the wow factor
  • You are struggling to get the attention of investors
  • You want to deliver a winning pitch at pitch competitions and events

Included in your Story Pitch™ Ready program:

StoryPitch™ scan: an in-depth assessment of your existing narrative and pitch decks to spot where we can strengthen your positioning, structure, and messaging.

Pitch deck: your most important fundraising tool. We create a professionally designed investor deck that sets you apart from the rest of your competitors and helps you take the conversation with investors to the next level.

Bonus: a complimentary copy of our book ‘Winners Have a Story.’

Read more about how we differentiate biotech companies

Bold and ready to disrupt the status quo

LenioBio is a life science biotech offering a disruptive protein expression technology.

On March 7, 2022, LenioBio announced closing its Series-A Extension round with a total investment volume of €11.5 million.

“Excellent investment! Chiaro created a convincing and brilliant pitch deck for our company. Wherever we present, everybody loves it.”

Remberto Martis

CEO, LenioBio